Dyne Therapeutics, Inc. financial statements
Dyne Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 446.21M | 10-K |
| Cash and equivalents | USD 893.37M | 10-Q |
| Total debt | USD 148.92M | 10-Q |
Dyne Therapeutics, Inc. financials on 6ix · Dyne Therapeutics, Inc. on 6ix